In Nikolic’s study, BMP9 was identified as a sensitive and specific biomarker of PoPH, which could predict transplant-free survival and the presence of PAH in liver disease [10]. Here, GDF2 is linked to Pulmonary arterial hypertension associated with portal hypertension.